PATENT CLAIM ANALYSIS

Application Number: 16202008
Application Type: Utility
Filing Date: 2018-11
Publication Date: 2019-08
Patent Classification: ["604", "506000"]

Abstract:
Plantar Heel Pain Syndrome can be of one or more etiologies and symptoms which refutes the mistaken tendency to categorize all plantar heel pain singularly as either plantar fasciitis or fasciosis. Recognizing that there is likely an interplay of inflammatory, degenerative and neuropathic etiologic conditions of this often-difficult malady to treat, a novel injection paradigm of botulinum toxin is explored in the treatment of 4 distinct presentations of Plantar Heel Pain Syndrome with promising results.

Claim (Index 1):
A method of treating Plantar Heel Pain Syndrome/Plantar Fasciitis in a patient in need thereof, said method comprising injecting a botulinum toxin into the insertional plantar fascia area of each of the Abductor Hallucis and Quadratus Plantae muscles in a foot of the patient affected by the Plantar Heel Pain Syndrome.

Metadata:
- Claim Count in Document: 16.0
- Percentile: 98.0
- Lexical Diversity: 1.27419
- Patent Class: 604.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['11504198', '14791389', '11056382', '16178334', '15917492']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.782051562503214
- 35 USC 102 Novelty (BERT): 0.4853052709512688
- Combined Prediction Score: 0.7523769333480194
- Mean Citation Score: 223.106332
- Max Citation Score: 231.65848
- Similarity Product: 167.17228357936858

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test